Enzyme vs Scallop — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Scallop trades at Rp167.58 (market cap Rp25,48M, Rp12,01M 24h volume). The key difference: Enzyme is far larger — about 5.3× Scallop's market cap, and Scallop's supply is capped (163,5M / 250M SCA (66%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Scallop for 13 Days on average.
| MLN | SCA | |
|---|---|---|
Market Cap | Rp134,13M | Rp25,48M |
Volume (24h) | Rp104,56M | Rp12,01M |
Circulating Supply | 3,3M MLN | 163,5M / 250M SCA (66%) |
Typical Hold Time | 28 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Scallop (SCA) is trading at Rp168.32 with a market cap of Rp25.17 million, showing bullish technical signals despite bearish moving averages. The token has 66% of its max supply in circulation with an average hold time of 13 days. Recent ETF inclusion by GraniteShares in May 2026 provides institutional exposure, though the news articles reference equity ETFs rather than direct cryptocurrency developments.
Overall outlook is cautiously optimistic with technical strength but limited fundamental catalysts. Key opportunities include institutional ETF exposure and neutral oscillator positioning. Major risks include high RSI_6 at 89.40 (overbought), low market cap vulnerability, and the token's relatively new market presence requiring careful risk management.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Scallop is an advanced decentralized finance (DeFi) protocol built on the Sui blockchain. It offers a wide range of financial services, including lending, borrowing, automated market making (AMM), and asset management. Developed by Scallop Labs, which has a team of experts in DeFi, cybersecurity, and fintech, Scallop has attracted support from notable investors such as CMS Holdings, 6th Man Ventures, KuCoin Labs, and Mysten Labs. Additionally, it is the first DeFi project to receive an official grant from the Sui Foundation, highlighting its institutional-grade quality and strong security features.
Read more on SCA →